title: Rationale for a study adding tamoxifen to HRT.
authors.affiliation: European Institute of Oncology, Milan, Italy. nicole.rotmensz@ieo.it
authors.forename: N
authors.initials: N
authors.lastname: Rotmensz
authors.forename: A
authors.initials: A
authors.lastname: Decensi
authors.forename: P
authors.initials: P
authors.lastname: Maisonneuve
authors.forename: A
authors.initials: A
authors.lastname: Costa
authors.forename: V
authors.initials: V
authors.lastname: Sacchini
authors.forename: R
authors.initials: R
authors.lastname: Travaglini
authors.forename: G
authors.initials: G
authors.lastname: D'Aiuto
authors.forename: F
authors.initials: F
authors.lastname: Lovison
authors.forename: G
authors.initials: G
authors.lastname: Gucciardo
authors.forename: M G
authors.initials: MG
authors.lastname: Muraca
authors.forename: M A
authors.initials: MA
authors.lastname: Pizzichetta
authors.forename: S
authors.initials: S
authors.lastname: Conforti
authors.forename: C
authors.initials: C
authors.lastname: Robertson
authors.forename: P
authors.initials: P
authors.lastname: Boyle
authors.forename: U
authors.initials: U
authors.lastname: Veronesi
mesh_terms: D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D020249:Hormone Replacement Therapy / Q000379:methods*; D006801:Humans; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage*; D013629:Tamoxifen / Q000008:administration & dosage*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen